EyePoint Pharmaceuticals (EYPT) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: EYPT) | Delayed: 0.40 -0.03 (6.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.43 | 52 Week High | $ | |||
| Open | $0.42 | 52 Week Low | $ | |||
| Day High | $0.43 | P/E | N/A | |||
| Day Low | $0.40 | EPS | $ | |||
| Volume | 13,326,245 | |||||
